Remedia
Articles
Brief Reports
Claim Reviews
Claims
Tools
About
Language
🌐
Login
Public evidence desk
Big Pharma chose to use mRNA technology for COVID-19 vaccines because their patents were nearing expiration.
Mostly False
Mostly False
Claimed by
Evidence
Claim Review: Did Big Pharma Choose mRNA Technology Due to Expiring Patents?
Content you might like:
Simple Empty
No data